Catalpol enhances the expression of brain-derived neurotrophic factor (BDNF) by upregulating the phosphorylation of cAMP response element-binding protein (CREB), improving the survival of -amyloid (A)-damaged SH-SY5Y neuroblastoma cells, and providing a theoretical basis for its neuroprotective effects in Alzheimers disease ( In summary, catalpol has demonstrated robust in vitro and in vivo neuroprotective activity against various neurological conditions, including those induced by rotenone, OGD/reoxygenation in SH-SY5Y cells, lead in PC12 cells, LPS in BV-2 cells, traumatic brain injury, spinal cord injury, cognitive impairment, and Alzheimers disease
This is Daves second time on the podcast, and its a nuanced exploration of what it means to live with vitality and consciousness in a world obsessed with optimization
Both peptides are usually given as small shots under the skin
Havoc Research cares about transparency above all
10.1016/j.conb.2011.12.006 Curr
Park, H